MARKETS / NASDAQ / SLAB
NASDAQ · SEMICONDUCTORS & RELATED DEVICES · LARGE CAP

Silicon Laboratories Inc. SLAB

18 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$784.8M
▲ 34.3% vs FY2024
EPS · FY25
$-1.98
Dividend / sh · FY25
Payout · FY25
ROE · FY25
-6.0%
Net margin · FY25
-8.3%
Dividend coverage
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 784.8M
Revenue, FY2025 · full 18-year series below
Revenue Net income
0.40.81.20.8-0.12008201120142017202020232025
0.40.81.20.8-0.12016201920222025

The company lost 8 cents on every revenue dollar this year.

Per share
USD -1.98
Diluted EPS, FY2025
EPS
204060-1.982008201120142017202020232025
204060-1.982016201920222025

The company pays no cash dividend.

Profitability
-6.0%
Return on equity, FY2025
ROE
4080120160-6.0%2008201120142017202020232025
4080120160-6.0%2016201920222025
Operating margin-9.0%
Net margin-8.3%
Return on assets-5.2%

Each USD of equity lost 6 cents this year.

Returned to shareholders
returned in FY2025 · dividends + net buybacks
Dividends paid
Net buybacksUSD -14.6M
Share of profit-0.0%
Consecutive raises

Growth
+9.0% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−8.5%
+9.0%
+2.0%
+3.1%

Compound annual rates per period — left blank where the series crosses a loss.

Share base
0.03B
Shares outstanding, FY2025
0.050.032008201120142017202020232025
0.040.032016201920222025
Change, 5 years−25.0%
Change, 10 years−21.0%

The share count shrank 25% in five years — the same company, cut into fewer, larger slices.

Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 1.3B
total assets, end of FY2025
Total assetsUSD 1.3B
EquityUSD 1.1B
CashUSD 364.2M
Current ratio4.69×

Equity funds 86% of total assets.

History
18 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Revenue $B
0.8
0.6
0.8
1.0
0.7
0.5
0.5
0.9
0.8
0.7
0.6
0.6
0.6
0.6
0.5
0.5
0.4
0.4
Operating income $B
−0.1
−0.2
−0.0
0.1
−0.0
−0.1
−0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.0
EBITDA $B
−0.0
−0.1
0.0
0.1
−0.0
−0.1
−0.1
0.1
0.1
0.1
0.0
0.1
0.1
0.1
0.1
0.1
0.1
0.1
Income tax $B
0.0
0.0
0.0
0.0
0.0
−0.0
0.0
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
−0.0
0.0
Net income $B
−0.1
−0.2
−0.0
0.1
2.1
0.0
0.0
0.1
0.0
0.1
0.0
0.0
0.0
0.1
0.0
0.1
0.1
0.0
EPS, diluted $
−1.98
−5.93
−1.09
2.54
47.78
0.28
0.43
1.90
1.09
1.45
0.69
0.87
1.14
1.47
0.79
1.57
1.57
0.67
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
−6.0
−16.7
−2.6
5.1
124.1
1.1
1.8
8.3
5.3
7.7
3.9
5.1
7.2
10.2
5.8
11.7
12.9
6.6
Shares out B
0.03
0.03
0.03
0.03
0.04
0.04
0.04
0.04
0.04
0.04
0.04
0.04
0.04
0.04
0.04
0.04
0.05
·

Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.

How we verifyAUDITED
70 of 70
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity

Every figure was compared against the original statement: 0 failures and 0 presentation gaps.

What we don’t show

We’d rather say what’s missing than fill the gap with an estimate.

P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed